دورية أكاديمية

An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1

التفاصيل البيبلوغرافية
العنوان: An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1
المؤلفون: Evitt, Lee A.Aff1, IDs12981023005071_cor1, Nanji, Sakina, Grove, Richard A., Okoli, Chinyere, van Wyk, Jean, Snedecor, Sonya J.
المصدر: AIDS Research and Therapy. 20(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17426405
DOI:10.1186/s12981-023-00507-1